The Potential of AI in Your Hands.

EVIDENS, our AI platform enables digital cohort discovery, research, collaboration, and insight sharing on hospital-wide data sets.

Unlock the Full Potential of Your Data

  • Quickly annotate and link your data into AI-ready data sets
  • Quickly filter populations based on clinical outcomes or demographics
  • Filter populations with limitless keywords by training AI models to search with them
Request Info

Leverage AI to Derive Clinical Insights

  • Explore and create criteria to identify cohorts with smart AI assistance
  • Quickly train AI models to automate analysis and categorize data into groups
  • Output AI-ready cohorts to test your study’s clinical hypothesis
Request Info

Enable Collaboration & Federated Learning

  • Easily view the status and tasks for all your projects and collaborators
  • View and follow activity based on your research interests and projects
  • Use collaborative tools to work in parallel to create, train and validate AI models
Request Info

Our Platform Partners

The latest on EVIDENS

Imagia Partners with Top US and Canadian Hospitals to Facilitate AI Accelerated Healthcare Discoveries

Imagia Partners with Top US and Canadian Hospitals to Facilitate AI Accelerated Healthcare Discoveries

New partnerships enable hospitals to access the Imagia EVIDENS™ AI platform, empowering clinicians to utilize cohorted and structured real

...
Read more
$2.6M to fight cancer using innovative technologies and artificial intelligence

$2.6M to fight cancer using innovative technologies and artificial intelligence

Created by leading financiers wanting to combine academic research and industry expertise, the Onco-Tech Competition is an opportunity for Q

...
Read more
The Promise of Prescribing AI to Cure Lung Cancer

The Promise of Prescribing AI to Cure Lung Cancer

In a forest of data, AI can find abnormalities within seconds. Now apply this principle to finding atypical cancer cells among the healthy o

...
Read more

Interested in a demo of the EVIDENS platform?

Contact us